300
Participants
Start Date
May 31, 1997
Primary Completion Date
February 29, 2008
doxorubicin hydrochloride
Given IV
ranpirnase
Given IV
Istituto Nazionale per la Ricerca sul Cancro, Genoa
Ospedale San Martino, Genoa
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore
Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia
CCOP - Northern Indiana CR Consortium, South Bend
Spectrum Health Hospital - Butterworth Campus, Grand Rapids
Missouri Cancer Care, PC at St. Joseph Health Center - St. Charles, Saint Charles
CCOP - Duluth, Duluth
Methodist Estabrook Cancer Center, Omaha
University of New Mexico Cancer Research and Treatment Center, Albuquerque
Asklepios Fachkliniken Muenchen-Gauting, Gauting
Hospital Grosshansdorf, Großhansdorf
Asklepios Klinik St. Georg, Hamburg
Asklepios Klinik Harburg, Hamburg
Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich
Medical University of Gdansk, Gdansk
University School of Medical Sciences, Poznan
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw
Klinika Chrorob Pluc I Gruzlicy, Zabrze
Lead Sponsor
Alfacell
INDUSTRY